0001203311-18-000087.txt : 20180919 0001203311-18-000087.hdr.sgml : 20180919 20180919183603 ACCESSION NUMBER: 0001203311-18-000087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180917 FILED AS OF DATE: 20180919 DATE AS OF CHANGE: 20180919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIEGALL CLAY B CENTRAL INDEX KEY: 0001167496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 181078421 MAIL ADDRESS: STREET 1: 21823 30TH DR SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-09-17 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001167496 SIEGALL CLAY B 21823 30TH DRIVE SE BOTHELL WA 98021 1 1 0 0 President and CEO Common Stock 2018-09-17 4 M 0 9931 12.16 A 742544 D Common Stock 2018-09-17 4 S 0 9931 76.36 D 732613 D Common Stock 2018-09-17 4 M 0 8827 12.16 A 741440 D Common Stock 2018-09-17 4 S 0 8827 77.2 D 732613 D Common Stock 2018-09-17 4 M 0 1390 12.16 A 734003 D Common Stock 2018-09-17 4 S 0 1390 78.0 D 732613 D Non-Qualified Stock Option (right to buy) 12.16 2018-09-17 4 M 0 9931 0.0 D 2019-08-25 Common Stock 9931 231846 D Non-Qualified Stock Option (right to buy) 12.16 2018-09-17 4 M 0 8827 0.0 D 2019-08-25 Common Stock 8827 223019 D Non-Qualified Stock Option (right to buy) 12.16 2018-09-17 4 M 0 1390 0.0 D 2019-08-25 Common Stock 1390 221629 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Reflects sales of common stock executed in multiple transactions at prices ranging from $75.81 to $76.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $76.81 to $77.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $77.83 to $78.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Shares vested at a rate of 25% on 8/25/10 and monthly thereafter until all the shares were fully vested on 8/25/13. /s/ Jean Liu 2018-09-19